Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Infusystem Holdings Inc Names Eric Steen Chief Executive Officer


Thursday, 14 Mar 2013 03:05pm EDT 

Infusystem Holdings Inc announced that its Board of Directors has appointed Eric Steen, who has more than 30 years of medical device and pharmaceutical industry experience, as Chief Executive Officer (CEO), effective April 1, 2013. Dilip Singh, who has served as the Company's Interim CEO since April 2012, will step down from that position on the same date, while continuing as a member of the Board. 

Company Quote

3.63
0.19 +5.52%
23 Oct 2014